MARKET

INOV

INOV

Inovalon Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

32.50
-0.06
-0.18%
Opening 09:48 06/22 EDT
OPEN
32.72
PREV CLOSE
32.56
HIGH
32.72
LOW
32.40
VOLUME
9.28K
TURNOVER
--
52 WEEK HIGH
33.20
52 WEEK LOW
17.56
MARKET CAP
5.07B
P/E (TTM)
150.46
1D
5D
1M
3M
1Y
5Y
Inovalon and Homecare Homebase ink multi-year exclusive agreement
Inovalon (INOV) and Homecare Homebase announce a multi-year exclusive agreement.Under the deal, Homecare would exclusively offer the EASE All-Payer application to their customers, representing more than 25% of the nation’s home health providers, to
Seekingalpha · 1h ago
BRIEF-Inovalon And Homecare Homebase Announce Multi-Year Exclusive Agreement
reuters.com · 1h ago
Inovalon and Homecare Homebase Announce Multi-Year Exclusive Agreement
Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, and Homecare Homebase, LLC (HCHB), the leading agency management and EMR software platform for the home health and hospice industry, today announced tha...
GlobeNewswire · 1h ago
Truist Securities Adjusts Price Target on Inovalon Holdings to $45 From $36, Maintains Buy Rating
MT Newswires · 1d ago
Stocks That Hit 52-Week Highs On Monday
  During Monday's morning session, 255 companies made new 52-week highs.
Benzinga · 06/14 14:38
3 Monster Growth Stocks That Could Reach New Highs
Let’s talk about growth stocks. These are stocks that have shown strong and sustained share price appreciation, sometimes ranging into triple-digit gains over the course of a year or more. In short, these are stocks that make investors say, “If only I’d bo...
TipRanks · 06/13 15:03
Stocks That Hit 52-Week Highs On Wednesday
    During Wednesday's morning trading, 251 companies set new 52-week highs.
Benzinga · 06/09 14:05
Inovalon Holdings Stock Is Believed To Be Significantly Overvalued
GuruFocus News · 06/05 14:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of INOV. Analyze the recent business situations of Inovalon Hldg through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average INOV stock price target is 36.00 with a high estimate of 45.00 and a low estimate of 22.00.
EPS
Institutional Holdings
Institutions: 240
Institutional Holdings: 54.79M
% Owned: 35.14%
Shares Outstanding: 155.89M
TypeInstitutionsShares
Increased
51
5.10M
New
28
2.78M
Decreased
70
5.25M
Sold Out
26
1.58M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
IT Services & Consulting
0.00%
Software & IT Services
+0.30%
Key Executives
Chairman/Chief Executive Officer/Director
Keith Dunleavy
Chief Financial Officer
Jonathan Boldt
Chief Administrative Officer
Peter De Bock
Other
Jason Capitel
Independent Director
Denise Fletcher
Independent Director
William Green
Other
June D. Duchesne
Independent Director
Isaac Kohane
Independent Director
Mark Pulido
Independent Director
Lee Roberts
Independent Director
William Teuber
Independent Director
Mark A. Pulido
No Data
About INOV
Inovalon Holdings, Inc. (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Through the Inovalon ONE Platform, the Company enables to interconnect with the healthcare ecosystem, aggregate and analyze data in real-time, and empower the application of resulting insights. Leveraging data interconnectivity capabilities, unparalleled data sets, analytics, data-driven intervention systems. The Company serves clients across the healthcare industry, which includes health plans and provider organizations, pharmaceutical, medical device, and diagnostics companies. It provides technology that supports approximately 500 healthcare organizations. Inovalon's platforms are informed by data pertaining to more than 941,000 physicians, 483,000 clinical facilities, 243 million Americans and 38 billion medical events.

Webull offers kinds of Inovalon Holdings Inc stock information, including NASDAQ:INOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INOV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INOV stock methods without spending real money on the virtual paper trading platform.